Contract Research Organization (CRO) Market Analysis North America,Europe,Asia,Rest of World (ROW) - US,Canada,Germany,UK,China - Size and Forecast 2024-2028

Published: Nov 2023

Pages: 174

SKU: IRTNTR73340

Snapshot

Contract Research Organization (CRO) Market Forecast 2024-2028

The contract research organization (CRO) market size is estimated to grow by USD 63.35 billion at a CAGR of 12.61% between 2023 and 2028. The accelerated growth of the market is due to various factors such as the growth of the biopharmaceutical industry, the increasing prevalence of chronic disease, and the increase in M&A activities by companies.

What will be the size of the Market During the Forecast Period?

For More Highlights About this Report, Download Free Sample in a Minute

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Market Driver

An increase in M&A activities by companies is the key factor driving market. This trend is fundamentally reshaping the industry landscape, driven by the pursuit of strategic advantages and the focus on attaining market leadership. Larger CROs are actively engaging in M&A activities to consolidate their position, improve their service capabilities, and expand their geographic reach. Business strategies such as M&A activities allow CROs to accelerate the research process, drug development, and other processes.

For instance, in December 2021, Thermo Fisher acquired PPD, Inc. (PPD), a leading global provider of clinical research services to the biopharma and biotech industry. Therefore, an increase in M&A activities by market players will continue to drive the development of the market and, in turn, will propel the growth of the market during the forecast period.

Market Trends

Capacity utilization and constraints are the primary trend in the market. Capacity utilization is the extent of existing production corresponding with the potential production of the company when the capacity is completely utilized. Most CROs face a challenge with developing advanced downstream purification technologies, which are used for the recovery and purification of biosynthetic products compared with the production of biological drugs. The high cost of downstream purification is further restricting the CROs from operating at their optimum capacity.

Moreover, factors such as the limited number of approved manufacturing facilities are also causing a capacity constraint. The shortage of cost-effective single-use products and the limitations of advanced cell culture systems for upstream performance are also causing constraints for the global market. Thus, such limitations may impede the market during the forecast period.

Market Challenge

A shortage of skilled professionals is a challenge that affects market. CROs require skilled personnel and appropriate training. Pharmaceutical and biotechnology manufacturing facilities and laboratories want to produce products in short time spans. Therefore, the lack of required skills leads to a high degree of non-compliance among laboratory professionals. In addition, the lack of skilled professionals is the root cause of non-compliance of laboratory safety workers and researchers, which negatively affects the manufacturing process and, ultimately, the quality of biopharmaceuticals.

Furthermore, CROs face challenges in attracting and retaining highly skilled professionals as they compete with pharmaceutical, biotechnology, and medical device companies and academic and research institutions for qualified and experienced scientists. Moreover, the shortage of skilled professionals will inhibit the adoption of new technologies, methodologies, and clinical trials. This will impede the the market during the forecast period.

Customer Landscape

The market research and growth report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market growth and forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their strategies.

Customer Landscape

Who are the Major Contract Research Organization (CRO) Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Charles River Laboratories International Inc.: The company offers preclinical CRO services to provide a full range of in vivo and in vitro testing evaluations and regulatory support for the safety assessment of pharmaceuticals, medical devices, and animal health products as well as chemicals, agrochemicals, and biocides.

The market forecasting report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Segmentation

The clinical research segment is estimated to witness significant growth during the forecast period. Clinical research services, a key offering of CROs, contain strategic planning, meticulous execution, and comprehensive oversight of clinical trials. CROs play a key role in providing compliance to regulatory guidelines, implementing rigorous monitoring, and maintaining data quality throughout the trial process.

Get a glance at the market contribution of various segments Download the PDF Sample

The clinical research segment was the largest segment and was valued at USD 28.47 billion in 2018. Research centers perform a broad range of tissue-based clinical research. The research operations are sponsored by key players or government entities, which, in turn, will help them to enhance R&D activities. Furthermore, CROs have been witnessing various developments to support clinical research. Thus, such factors will spur the growth of the segment and, in turn, the market during the forecast period.

Regional Analysis

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The market players such as Charles River Laboratories, Laboratory Corporation of America, and Parexel are some of the major CROs that are headquartered in the region and provide R&D services globally. Factors such as access to a large patient pool for various indications to conduct late-stage clinical trials are contributing to the regional market.

Furthermore, due to this significant growth of the biopharmaceutical and medical device industries in the US, the number of new products, such as drugs, vaccines, and medical disposables, is increasing. The increased number of products fuels the demand for safety, efficacy, and acceptance of the product, which is driving the demand for clinical trials. Due to the growing demand for clinical trials, there is a rise in clinical trial supplies by market players. Thus, this resulted in a rise in demand for the regional market during the forecast period.

Market Analyst Overview

The Contract Research Organization (CRO) Market is witnessing significant growth attributed to the expanding R&D budgets of pharmaceutical and medical device manufacturers, alongside the increasing prevalence of chronic diseases like cardiovascular diseases, obesity, diabetes, cancer, and neurological disorders. CROs like Pharmaceutical Product Development, LLC and Science 37 are playing pivotal roles in supporting clinical trial management and non-clinical research activities across therapeutic areas such as oncology, CNS disorders, cardiology, metabolic disorders, infectious diseases, and immunological disorders.

With the rise of precision medicine and research initiatives focusing on diseases like Alzheimer's, dementia, Parkinson's disease, and HIV/AIDS, CROs are collaborating with academic institutes, research organizations, and governments worldwide. The United States, European Union, Asia Pacific, Latin America, Middle East, and Africa are key regions driving the CRO Services market forward.

Prominent companies in this sector are diversifying their offerings, including early phase development services, laboratory services, consulting services, and data management services. Moreover, the adoption of decentralized clinical trial Software as a Service (SaaS) is transforming patient recruitment and retention strategies. Industry trend analysis, pricing analysis, and patent analysis are crucial factors shaping buying behavior and influencing key stakeholders in the CRO market.

Segment Overview

The market growth analysis report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and opportunities from 2018 to 2028.

Application Outlook
- Clinical research
- Early phase development
- Laboratory
- Regulatory consulting

End-user Outlook
- Pharmaceutical and biopharmaceutical companies
- Medical device companies
- Academic institutes

Region Outlook
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- Rest of the World (ROW)
  - Argentina
  - Australia
  - Brazil

Contract Research Organization (CRO) Market Scope
Market Report Coverage	Details
Page number	174
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 12.61%
Market Growth 2024-2028	USD 63.35 billion
Market structure	Fragmented
YoY growth 2023-2024(%)	11.64
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 40%
Key countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	BioAgile Therapeutics Pvt. Ltd, Charles River Laboratories International Inc., Clinical Trial Service B.V., CTI Clinical Trial and Consulting Inc., Ergomed Plc, Eurofins Scientific SE, Geneticist Inc., Hangzhou Tigermed Consulting Co. Ltd., ICON plc, IQVIA Holdings Inc., Konecranes, Laboratory Corp. of America Holdings, Linical Co. Ltd., Medpace Holdings Inc., Novotech Health Holdings, Parexel International Corp., Pharmaron Beijing Co. Ltd., Syneos Health Inc., Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download PDF Sample

What are the Key Data Covered in this Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the market between 2024 and 2028
Precise estimation of the market size and its contribution to the market in focus on the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market across North America, Europe, Asia, and the Rest of World (ROW)
A thorough analysis of the market’s competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements.

Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global contract research organization (CRO) market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global contract research organization (cro) market 2018 - 2022 ($ billion)

4.2 Application Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ billion)

4.3 End-user Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ billion)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Application - Market share 2023-2028 (%)

6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application

6.3 Clinical research - Market size and forecast 2023-2028
- Exhibit 34: Chart on Clinical research - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Clinical research - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Clinical research - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Clinical research - Year-over-year growth 2023-2028 (%)

6.4 Early phase development - Market size and forecast 2023-2028
- Exhibit 38: Chart on Early phase development - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Early phase development - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Early phase development - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Early phase development - Year-over-year growth 2023-2028 (%)

6.5 Laboratory - Market size and forecast 2023-2028
- Exhibit 42: Chart on Laboratory - Market size and forecast 2023-2028 ($ billion)
- Exhibit 43: Data Table on Laboratory - Market size and forecast 2023-2028 ($ billion)
- Exhibit 44: Chart on Laboratory - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Laboratory - Year-over-year growth 2023-2028 (%)

6.6 Regulatory consulting - Market size and forecast 2023-2028
- Exhibit 46: Chart on Regulatory consulting - Market size and forecast 2023-2028 ($ billion)
- Exhibit 47: Data Table on Regulatory consulting - Market size and forecast 2023-2028 ($ billion)
- Exhibit 48: Chart on Regulatory consulting - Year-over-year growth 2023-2028 (%)
- Exhibit 49: Data Table on Regulatory consulting - Year-over-year growth 2023-2028 (%)

6.7 Market opportunity by Application
- Exhibit 50: Market opportunity by Application ($ billion)
- Exhibit 51: Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by End-user

7.1 Market segments
- Exhibit 52: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 53: Data Table on End-user - Market share 2023-2028 (%)

7.2 Comparison by End-user
- Exhibit 54: Chart on Comparison by End-user
- Exhibit 55: Data Table on Comparison by End-user

7.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028
- Exhibit 56: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 57: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 58: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)

7.4 Medical device companies - Market size and forecast 2023-2028
- Exhibit 60: Chart on Medical device companies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 61: Data Table on Medical device companies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 62: Chart on Medical device companies - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Medical device companies - Year-over-year growth 2023-2028 (%)

7.5 Academic institutes - Market size and forecast 2023-2028
- Exhibit 64: Chart on Academic institutes - Market size and forecast 2023-2028 ($ billion)
- Exhibit 65: Data Table on Academic institutes - Market size and forecast 2023-2028 ($ billion)
- Exhibit 66: Chart on Academic institutes - Year-over-year growth 2023-2028 (%)
- Exhibit 67: Data Table on Academic institutes - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by End-user
- Exhibit 68: Market opportunity by End-user ($ billion)
- Exhibit 69: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 71: Chart on Market share by geography 2023-2028 (%)
- Exhibit 72: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 73: Chart on Geographic comparison
- Exhibit 74: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 China - Market size and forecast 2023-2028
- Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)

9.9 Germany - Market size and forecast 2023-2028
- Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.10 Canada - Market size and forecast 2023-2028
- Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.11 UK - Market size and forecast 2023-2028
- Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 111: Market opportunity by geography ($ billion)
- Exhibit 112: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 113: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 114: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 115: Overview on factors of disruption

11.4 Industry risks
- Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 117: Vendors covered

12.2 Market positioning of vendors
- Exhibit 118: Matrix on vendor position and classification

12.3 BioAgile Therapeutics Pvt. Ltd
- Exhibit 119: BioAgile Therapeutics Pvt. Ltd - Overview
- Exhibit 120: BioAgile Therapeutics Pvt. Ltd - Product / Service
- Exhibit 121: BioAgile Therapeutics Pvt. Ltd - Key offerings

12.4 Charles River Laboratories International Inc.
- Exhibit 122: Charles River Laboratories International Inc. - Overview
- Exhibit 123: Charles River Laboratories International Inc. - Business segments
- Exhibit 124: Charles River Laboratories International Inc. - Key news
- Exhibit 125: Charles River Laboratories International Inc. - Key offerings
- Exhibit 126: Charles River Laboratories International Inc. - Segment focus

12.5 CTI Clinical Trial and Consulting Inc.
- Exhibit 127: CTI Clinical Trial and Consulting Inc. - Overview
- Exhibit 128: CTI Clinical Trial and Consulting Inc. - Product / Service
- Exhibit 129: CTI Clinical Trial and Consulting Inc. - Key offerings

12.6 Ergomed Plc
- Exhibit 130: Ergomed Plc - Overview
- Exhibit 131: Ergomed Plc - Business segments
- Exhibit 132: Ergomed Plc - Key news
- Exhibit 133: Ergomed Plc - Key offerings
- Exhibit 134: Ergomed Plc - Segment focus

12.7 Eurofins Scientific SE
- Exhibit 135: Eurofins Scientific SE - Overview
- Exhibit 136: Eurofins Scientific SE - Business segments
- Exhibit 137: Eurofins Scientific SE - Key news
- Exhibit 138: Eurofins Scientific SE - Key offerings
- Exhibit 139: Eurofins Scientific SE - Segment focus

12.8 ICON plc
- Exhibit 140: ICON plc - Overview
- Exhibit 141: ICON plc - Product / Service
- Exhibit 142: ICON plc - Key offerings

12.9 IQVIA Holdings Inc.
- Exhibit 143: IQVIA Holdings Inc. - Overview
- Exhibit 144: IQVIA Holdings Inc. - Business segments
- Exhibit 145: IQVIA Holdings Inc. - Key news
- Exhibit 146: IQVIA Holdings Inc. - Key offerings
- Exhibit 147: IQVIA Holdings Inc. - Segment focus

12.10 Konecranes
- Exhibit 148: Konecranes - Overview
- Exhibit 149: Konecranes - Business segments
- Exhibit 150: Konecranes - Key offerings
- Exhibit 151: Konecranes - Segment focus

12.11 Laboratory Corp. of America Holdings
- Exhibit 152: Laboratory Corp. of America Holdings - Overview
- Exhibit 153: Laboratory Corp. of America Holdings - Business segments
- Exhibit 154: Laboratory Corp. of America Holdings - Key news
- Exhibit 155: Laboratory Corp. of America Holdings - Key offerings
- Exhibit 156: Laboratory Corp. of America Holdings - Segment focus

12.12 Medpace Holdings Inc.
- Exhibit 157: Medpace Holdings Inc. - Overview
- Exhibit 158: Medpace Holdings Inc. - Product / Service
- Exhibit 159: Medpace Holdings Inc. - Key offerings

12.13 Novotech Health Holdings
- Exhibit 160: Novotech Health Holdings - Overview
- Exhibit 161: Novotech Health Holdings - Product / Service
- Exhibit 162: Novotech Health Holdings - Key offerings

12.14 Parexel International Corp.
- Exhibit 163: Parexel International Corp. - Overview
- Exhibit 164: Parexel International Corp. - Product / Service
- Exhibit 165: Parexel International Corp. - Key news
- Exhibit 166: Parexel International Corp. - Key offerings

12.15 Syneos Health Inc.
- Exhibit 167: Syneos Health Inc. - Overview
- Exhibit 168: Syneos Health Inc. - Business segments
- Exhibit 169: Syneos Health Inc. - Key offerings
- Exhibit 170: Syneos Health Inc. - Segment focus

12.16 Thermo Fisher Scientific Inc.
- Exhibit 171: Thermo Fisher Scientific Inc. - Overview
- Exhibit 172: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 173: Thermo Fisher Scientific Inc. - Key news
- Exhibit 174: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 175: Thermo Fisher Scientific Inc. - Segment focus

12.17 WuXi AppTec Co. Ltd.
- Exhibit 176: WuXi AppTec Co. Ltd. - Overview
- Exhibit 177: WuXi AppTec Co. Ltd. - Business segments
- Exhibit 178: WuXi AppTec Co. Ltd. - Key offerings
- Exhibit 179: WuXi AppTec Co. Ltd. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 180: Inclusions checklist
- Exhibit 181: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 182: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 183: Research methodology
- Exhibit 184: Validation techniques employed for market sizing
- Exhibit 185: Information sources

13.5 List of abbreviations
- Exhibit 186: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

contract research organization (cro) market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis